BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension

BDX seeks CE Mark for its Liverty TIPS Stent Graft, a next-gen device aimed at improving portal hypertension treatment and ...

BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced application of ...
MedTech Intelligence

BD Announced Application of CE Mark for the Liverty TIPS Stent Graft

Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, this ...
Nasdaq

Galectin Therapeutics to Host Virtual Key Opinion Leader Event on MASH Cirrhosis and Portal Hypertension Treatment

Galectin Therapeutics is hosting a virtual key opinion leader (KOL) event to discuss the unmet needs in treating MASH cirrhosis and portal hypertension, positioning the company as a thought leader in ...
Healio

Xarelto boosts survival for portal hypertension in cirrhosis without hike in bleeding risk

Please provide your email address to receive an email when new articles are posted on . Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver ...

Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update

NORCROSS, Ga., March 31, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

Chinese Medical Association Publishing House Co., Ltd. Sheds Light on New Noninvasive Clues to Detect Portal Hypertension

Doppler ultrasound allows clinicians to assess blood flow direction and velocity in the portal vein and surrounding vessels. In cirrhosis, portal vein flow often slows, and in severe cases, it may ...